Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175
Authors
Keywords
-
Journal
PLoS Pathogens
Volume 9, Issue 5, Pages e1003390
Publisher
Public Library of Science (PLoS)
Online
2013-05-24
DOI
10.1371/journal.ppat.1003390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Epitope of Monoclonal Antibodies Blocking Erythrocyte Invasion by Plasmodium falciparum Map to The Dimerization and Receptor Glycan Binding Sites of EBA-175
- (2013) Xavier Ambroggio et al. PLoS One
- Identification of a Potent Combination of Key Plasmodium falciparum Merozoite Antigens That Elicit Strain-Transcending Parasite-Neutralizing Antibodies
- (2012) Alok K. Pandey et al. INFECTION AND IMMUNITY
- Crystal and Solution Structures ofPlasmodium falciparumErythrocyte-binding Antigen 140 Reveal Determinants of Receptor Specificity during Erythrocyte Invasion
- (2012) Daniel H. Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Sialic Acid Dependent and Independent Pathways of Invasion in Plasmodium falciparum
- (2012) Rosalynn Louise Ord et al. PLoS One
- Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens
- (2012) Andrew R. Williams et al. PLoS Pathogens
- Cross-Linking of Rotavirus Outer Capsid Protein VP7 by Antibodies or Disulfides Inhibits Viral Entry
- (2011) S. T. Aoki et al. JOURNAL OF VIROLOGY
- Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC
- (2011) Joseph D Batchelor et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Antibodies to Plasmodium falciparum Erythrocyte-binding Antigen-175 are Associated With Protection From Clinical Malaria
- (2011) Matthew B. McCarra et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Vaccines against malaria
- (2011) A. V. S. Hill PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Delineation of Stage Specific Expression of Plasmodium falciparum EBA-175 by Biologically Functional Region II Monoclonal Antibodies
- (2011) B. Kim Lee Sim et al. PLoS One
- Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine
- (2011) L. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- (2011) Alexander D. Douglas et al. Nature Communications
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic
- (2010) H. M. El Sahly et al. Clinical and Vaccine Immunology
- Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia
- (2010) Jack S. Richards et al. CLINICAL INFECTIOUS DISEASES
- Reticulocyte and Erythrocyte Binding-Like Proteins Function Cooperatively in Invasion of Human Erythrocytes by Malaria Parasites
- (2010) Sash Lopaticki et al. INFECTION AND IMMUNITY
- Advances and challenges in malaria vaccine development
- (2010) Peter D. Crompton et al. JOURNAL OF CLINICAL INVESTIGATION
- Super-resolution biomolecular crystallography with low-resolution data
- (2010) Gunnar F. Schröder et al. NATURE
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
- (2010) T. T. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Distinct External Signals Trigger Sequential Release of Apical Organelles during Erythrocyte Invasion by Malaria Parasites
- (2010) Shailja Singh et al. PLoS Pathogens
- Toward an Antibody-Based HIV-1 Vaccine
- (2009) James A. Hoxie Annual Review of Medicine
- DAMMIF, a program for rapidab-initioshape determination in small-angle scattering
- (2009) Daniel Franke et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Determination of the molecular weight of proteins in solution from a single small-angle X-ray scattering measurement on a relative scale
- (2009) H. Fischer et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS)
- (2009) Greg L Hura et al. NATURE METHODS
- Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1
- (2009) D. C. G. Mayer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of Rotavirus Outer-Layer Protein VP7 Bound with a Neutralizing Fab
- (2009) S. T. Aoki et al. SCIENCE
- Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria
- (2008) F. H. A. Osier et al. INFECTION AND IMMUNITY
- Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies
- (2008) Kristina E.M. Persson et al. JOURNAL OF CLINICAL INVESTIGATION
- Neutralization of HIV-1 by redirection of natural antibodies
- (2008) M. F. Perdomo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started